Member Spotlight



Transgenomic is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Our offering includes systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine.

Transgenomic WAVE Systems offer discovery and detection of genetic variations at close to 100% sensitivity, making them among the most sensitive and accurate technologies for detection of known and unknown mutations and single nucleotide polymorphisms (SNPs). These systems are used throughout the world to screen for a large variety of diseases. More than 350 human genes have been screened entirely or partly by DHPLC. A multitude of other applications are being used with WAVE Systems in such diverse areas as plant genomics, microbial analysis, and drug sensitivity. With close to 1,300 installations around the world, the WAVE System technology has been accepted worldwide.

Wave Systems are fully automated, robust, versatile and cost effective, meeting the critical requirements of leading academic and biopharmaceutical laboratories. WAVE Systems utilize DHPLC (denaturing high-performance liquid chromatography) in conjunction with the Transgenomic patented separation DNASep Cartridges for mutation detection.




 

UPCOMING EVENTS

March 24 - 25, 2010
SBIR Program Two-Day Workshop
April 6 - 8, 2010
UNL Research Fair
April 8 - 9, 2010
Ethanol 2010: Emerging Issues Forum
April 15, 2010
Bio Nebraska Annual Meeting 2010
May 3 - 6, 2010
BIO International 2010

view all...

MEMBER NEWS

Bio Nebraska Announces Annua...
March 16, 2010 Full Story
New Web Site Launched for Sci...
February 18, 2010 Full Story
Now Hiring: Formulations Oper...
February 18, 2010 Full Story
Bio Nebraska's Annual Meeting ...
February 18, 2010 Full Story
Deadline to Submit Nomination...
February 18, 2010 Full Story

view all...